Atrium Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atrium Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13k | 950 | 13.37 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors